Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Dec 15, 2021; 13(12): 2190-2202
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2190
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2190
Clinical characteristics | AR (n = 103) | NAR (n = 114) | P value |
Age, yr (mean ± SD) | 54.1 ± 12.5 | 51.3 ± 12.2 | 0.095 |
Sex, n (%) | 0.812 | ||
Male | 93 (90.3) | 104 (91.2) | |
Female | 10 (9.7) | 10 (8.8) | |
ALT (U/mL) | 30.5 ± 14.5 | 29.8 ± 14.2 | 0.721 |
AST (U/mL) | 36.3 ± 28.9 | 40.6 ± 34.6 | 0.332 |
TBiL (μmol/L) | 17.0 ± 10.5 | 15.9 ± 9.0 | 0.098 |
Child-Pugh score, n (%) | 0.154 | ||
A | 103 (100) | 106 (93.0) | |
B | 0 (0) | 2 (7.0) | |
HBsAg, n (%) | 0.622 | ||
Positive | 88 (85.4) | 100 (87.7) | |
Negative | 15 (14.6) | 14 (12.3) | |
Liver cirrhosis, n (%) | 0.841 | ||
No | 21 (20.4) | 22 (19.3) | |
Yes | 82 (79.6) | 92 (80.7) | |
AFP (ng/mL), n (%) | 0.446 | ||
< 400 | 71 (68.9) | 73 (64.0) | |
≥ 400 | 32 (31.1) | 41 (36.0) | |
ICG-R15 (%) | 5.9 ± 3.5 | 5.4 ± 3.1 | 0.578 |
BCLC stage, n (%) | 0.867 | ||
0 + A | 46 (44.7) | 46 (40.4) | |
B + C | 57 (55.3) | 68 (59.6) | |
Operation method, n (%) | 0.423 | ||
Open | 24 (23.3) | 32 (28.1) | |
Laparoscopic | 79 (76.7) | 82 (71.9) | |
Operation time (min) | 171.4 ± 48.2 | 165.5 ± 45.3 | 0.335 |
Blood loss (mL) | 210 ± 233 | 170 ± 175 | 0.233 |
Blood transfusion, n (%) | 0.774 | ||
No | 89 (86.4) | 100 (87.7) | |
Yes | 14 (13.6) | 14 (12.3) | |
Hepatic vascular occlusion, n (%) | 0.314 | ||
No | 27 (26.2) | 37 (32.5) | |
Yes | 76 (73.8) | 77 (67.5) | |
Largest tumor size, (cm) | 5.1 ± 3.6 | 4.7 ± 3.3 | 0.507 |
No. of tumors, n (%) | 0.884 | ||
Single | 75 (72.8) | 82 (71.9) | |
Multiple | 28 (27.2) | 32 (28.1) | |
Tumor encapsulation, n (%) | 0.051 | ||
No | 57 (55.3) | 66 (57.9) | |
Yes | 46 (44.7) | 48 (42.1) | |
Satellite lesion, n (%) | 0.822 | ||
Yes | 9 (8.7) | 9 (7.9) | |
No | 94 (91.3) | 105 (92.1) | |
Tumor differentiation stage, n (%) | 0.943 | ||
Edmondson I II | 51 (49.5) | 57 (50.0) | |
Edmondson III IV | 52 (50.5) | 57 (50.0) | |
Microvascular invasion, n (%) | 0.845 | ||
Yes | 37 (35.9) | 38 (33.3) | |
No | 66 (64.1) | 76 (66.7) |
- Citation: Zhou JM, Zhou CY, Chen XP, Zhang ZW. Anatomic resection improved the long-term outcome of hepatocellular carcinoma patients with microvascular invasion: A prospective cohort study. World J Gastrointest Oncol 2021; 13(12): 2190-2202
- URL: https://www.wjgnet.com/1948-5204/full/v13/i12/2190.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i12.2190